Announcements

  • PCPC

Developing the Next Generation PD-L1 Assays Using Precision Mass Spectrometry

The McGill node has received funding from the Genome Canada Genomic Applications Partnership Program (GAPP) to  develop PD-L1 Mass Spectrometry (MS)-based assays for use in immune-oncology.


View Full Article

0 views

Our Funding Partners

genome_canada_logo.png
CFI_WHT.png
Genome_BC_logo.png

© Pan-Canadian Proteomic Centre 2020